Encora, INC.
Doing business as Encora INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersBoston, MA
US patents4
SAM.gov UEIRZGGJ7HDA4J4
CAGE code8KZ37
Incorporated inDE
- Prescription required
- Patient Advocate
- gentle neurostimulation
- adults with essential tremor
- support throughout your day
- non-drug option
- Rx only
Named on the company’s own website, read JUL 29, 2026
What they make
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2023–2025, 4 of them in the five years to SEP 2025.
Medical technology 4
- Apparatus and method for reduction of neurological movement disorder symptoms using wearable deviceUS 12,318,342 · granted JUN 3, 2025
- Apparatus and method for reduction of neurological movement disorder symptoms using wearable deviceUS 12,318,341 · granted JUN 3, 2025
- Apparatus and method for reduction of neurological movement disorder symptoms using wearable deviceUS 11,839,583 · granted DEC 12, 2023
- Apparatus and method for reduction of neurological movement disorder symptoms using wearable deviceUS 11,701,293 · granted JUL 18, 2023
Granted to Encora, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Encora, INC. | Boston | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.